Default company panoramic image

EpiCypher Inc

EpiCypher offers novel research tools developed by cutting edge scientists for a growing market linked to cancer and stem cell biology.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Chapel Hill, NC, USA
  • Currency USD
  • Founded January 2012
  • Employees 3
  • Website

Company Summary

EpiCypher develops and sells novel, high value consumables for the epigenetics and chromatin biology research market. This area of research is growing rapidly due to its involvement in all aspects of genetics, including cancer and stem cell biology. Our customers are researchers at universities, hospitals, biotechnology and pharmaceutical companies across the world. Our products will be in high demand as they are unique and of the highest quality


  • Default avatar
    Jim Bone, PhD

    Jim earned a Bachelor of Science degree from the University of North Carolina at Chapel Hill and a PhD from Baylor College of Medicine. He was a post-doctoral fellow in Sharon Dent’s lab at the University of Texas MD Anderson Cancer Center and then later in the lab of David Allis at the University of Virginia. Jim worked for Upstate Biotechnology for six years, directing their efforts producing and selling products for chromatin biology and epige

  • Default avatar
    Zu-Wen Sun, PhD
    Chief Scientific Officer

    Dr. Zu-Wen Sun was an Assistant Professor in the Department of Biochemistry at Vanderbilt University School of Medicine. He received a PhD from the Louisiana State University Health Sciences Center. He performed his post-doctoral studies with Dr. Michael Hampsey at the UMDNJ-Robert Wood Johnson Medical School and then later with Dr. C. David Allis at the University of Virginia. While in Dr. Allis’ lab, Dr. Sun identified the first kinase responsi


  • Default avatar
    Fred Hutchison
    Default avatar
    Bob Harris